LGNXZStock
LIGAND PHARMACEUTICALS INC
Price data unavailable
Track LGNXZ in your trading journalAbout LIGAND PHARMACEUTICALS INC
LIGAND PHARMACEUTICALS INC (LGNXZ) is a US-listed equity tracked across major market indices. LIGAND PHARMS GLUCAGON
The company reports trailing twelve-month revenue of $56.16M and net loss of $13.35M. Key metrics include a return on equity of -1.3%, a debt-to-equity ratio of 0.54.
FINOTAUR provides free research summaries, news aggregation, and fundamentals for LGNXZ to support both active traders and long-term investors.
Fundamentals
| Revenue (TTM) | $56.16M |
| Net Income (TTM) | $-13.35M |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | -1.34% |
| Debt-to-Equity | 0.54 |
| Dividend per Share | — |
Recent News
No recent news available.
Want real-time analysis on LGNXZ?
Track it free in your trading journal. Log trades, tag setups, and review your edge.